Skip to content

Author

Eli Johnson

We have 2 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Current Trends in Therapeutic Outcomes Among Patients With Metastatic Renal Cell Carcinoma of the Spine: A Systematic Review and Meta-Analysis

Study Design Systematic Review. Objectives The objective of this study was to answer two questions: (1) Did the overall survival (OS) of patients with spinal metastatic renal cell carcinoma (mRCC) improve in publications from 2017 and afterwards compared to 2016 and before? (2) Did the rate of improvement in pain or ne...

Tobechukwu C. Ndika, Joshua Woo, Brandon T. Lee et al. · 0 citations
Review Open access Aug 2026

SUPC-05 FRAILTY AND SARCOPENIA IN SPINAL ONCOLOGY: A SYSTEMATIC REVIEW

Frailty and sarcopenia are common in the MSD population and multidimensional measurements of health that must be carefully considered with regard to treatment decision making, however, this review reinforces the lack of readily available tool to quantify both conditions and their effect on outcomes.

Eli Johnson, Mark A. Maclean, Antoinette J. Charles et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.